“If you use a Google maps analogy,” explains Alex Ward, PhD, co-founder of Tolemy Bio. “Then we’re bypassing bottlenecks in ...

OpenAI and Google revealed fresh AI breakthroughs showing different technology paths in artificial intelligence research. Companies are battling to control how ...

Artificial intelligence startup Perplexity launched an agent-based assistant for Android devices on Thursday as it looks to take on larger rival OpenAI's ChatGPT and incumbent assistants such as Apple ...

Google has announced a major upgrade for its artificial intelligence (AI) assistant, Gemini. The upgrade, announced at the ...

All season long, Gold Derby has been checking in with Gemini AI for its Oscar nominations predictions, and we’ve had a good ...

On his second day in office, President Donald Trump unveiled a joint, private-sector venture to fund billions of dollars in U ...

Alexandr Wang, CEO of Scale AI, speaking on CNBC’s Squawk Box outside the World Economic Forum in Davos, Switzerland on Jan. 23rd, 2025. Alexandr Wang, whose company Scale AI provides training data to ...

Samsung is injecting another dose of artificial intelligence into the next version of its Galaxy smartphones, escalating an ...

Google Cloud provided the Israel Defense Forces and Defense Ministry with artificial intelligence (AI) technology during the Israel/Gaza war. Reported by The Washington Post, which cites internal ...

Dan Loeb is swapping out one of the cheapest industry-leading AI stocks for another with well-defined competitive advantages and a nosebleed valuation.

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

The CEO of one of the leading AI companies has confidently said AI capabilities will surpass almost all humans in everything we can do.